Putting the brakes on an enzyme might rescue neurons that are dying in Parkinson's disease, stabilizing the progression of ...

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic mutation.

Combining natural organic atoms with metal complexes, scientists at The Wistar Institute have developed a new type of enzyme inhibitor capable of blocking a biochemical pathway that plays a key ...

Major players in the enzyme inhibitor market are Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Bayer AG, F. Hoffmann-La Roche AG, Pfizer Inc., Ranbaxy Laboratories, Takeda Pharmaceutical ...

By combining two antioxidant enzyme inhibitors, researchers have converted cancer cells in mice into healthy nerve cells.

PARP inhibitors are a type of cancer drug. PARP stands for poly adenosine diphosphate-ribose polymerase, a type of enzyme that helps repair DNA damage in cells. PARP inhibitors work by preventing ...

Background: Angiotensin-converting-enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are effective treatments for diabetic retinopathy, but randomized trials and meta-analyses ...

"Gene Inhibition May Help Normalize Type 2 Diabetes." ScienceDaily. www.sciencedaily.com / releases / 2009 / 06 / 090618173246.htm (accessed May 15, 2025). Explore More ...

More information: Hyeong Jun Jang et al, Optimizing enzyme inhibition analysis: precise estimation with a single inhibitor concentration, Nature Communications (2025). DOI: 10.1038/s41467-025-60468-z ...